Vir Biotechnology, Inc. — Director's Dealing 2020

Nov 12, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vir Biotechnology, Inc. (VIR)
CIK: 0001706431
Period of Report: 2020-11-10

Reporting Person: Virgin Herbert (EVP, Research & CSO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-10	Common Stock	M	2340	$1.53	Acquired	26040	Direct
2020-11-10	Common Stock	S	2340	$26.26	Disposed	23700	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-10	Stock Option (Right to Buy)	$1.53	M	2340	Disposed	2028-01-26	Common Stock (2340)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020.

F2: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.